Diabetes is a long-term condition where too much sugar stays in the blood. If not managed well, it can get worse over time, ...

Discover the details about Wegovy, a popular weight loss drug now available for telehealth purchase. Understand its benefits, ...

Healthify is banking on the rise of GLP-1 weight-loss drugs in India, integrating them with lifestyle coaching. The firm ...

Approved by India’s apex drug regulatory body, the weight-loss drug is a once-weekly injection priced at Rs 4,375 for a 5 mg ...

Hims & Hers partners with Novo Nordisk to offer Wegovy access online with clinical support, expanding its weight loss care and revenue strategy.

The apparent success — and now almost ever-present ubiquity — of GLP-1 receptor agonists in weight loss has led to research, and possible uses, far beyond its initial indications in diabetes, ...

Mounjaro, the new weight loss drug, is gaining popularity in India for its rapid results. Patients report better appetite control, blood sugar management, and significant weight loss.

A batch of the drug is under a limited voluntary recall after a shipping error exposed certain doses to improper temperatures.

Just today, this drug became more widely available. Some product is now facing a recall following an apparent storage error.

While Berberine is touted as a natural alternative to Ozempic, its AMPK modulation differs from GLP-1 pathways, highlighting ...

Novo Nordisk has teamed up with Hims & Hers Health, LifeMD and Ro for cash-paying patients to access Wegovy injection 2.4 mg ...